Hematology coagulation analyzer & reagents - cprr
Active Purchase Order Awarded Last action
- Contract number
- W81K0023P0032
- Awardee
-
Diagnostica Stago Inc. UEI ND7MY2A4ZUE9
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $817,019
Award facts
- Opportunity
-
- Sources Sought Notice – Cost-Per-Reportable Result Coagulation Reagents for Analyzer Pre-Solicitation · W81K0023Q0001 · Posted May 12, 2022
- Contract value 65% obligated
-
- $1,121,114.02 Current, with exercised options
- $1,247,820.27 Potential, with all options
- Completion date 73% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- 2330 Stanley Rd, Fort Sam Houston, TX 78234, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $280,862 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Funding Only Action | $256,957 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $210,549 | |
| Funding Only Action | $45,666 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | -$45,970 | |
| Supplemental Agreement for work within scope | -$68,956 | |
| Funding Only Action | $137,911 | |
| Original award | $0 |
Show all 16
About this award
The Defense Health Agency awarded a firm-fixed-price purchase order to Diagnostica Stago Inc. on April 1, 2023, with a ceiling value of $1,247,820.27 for hematology coagulation analyzers and reagents supporting the coagulation and special coagulation mission at Brooke Army Medical Center. No set-aside was used, and the order's ultimate completion date is February 29, 2028. Performance is at 2330 Stanley Rd, Fort Sam Houston, TX 78234. The order covers coagulation reagents, instrumentation, consumables, and services for PT, PTT, fibrinogen, D-dimer, and anti-Xa testing, using FDA-approved reagents and analyzers validated and integrated with MHS Genesis. The prime is foreign-owned and holds no SBA socioeconomic certifications. The originating Pre-Solicitation Sources Sought Notice, posted May 12, 2022 with responses due May 19, 2022, was issued by the Regional Health Contracting Office - Central on behalf of the San Antonio Military Medical Center. It specified a cost-per-reportable agreement for fiscal years 2023 through 2027 under NAICS 334516, with PSC codes 6505, 6515, and R499 also applicable.
Quick answers
Who was awarded contract W81K0023P0032?
W81K0023P0032 was awarded to Diagnostica Stago Inc. by Medical Command (Department of the Army) on April 1, 2023.
How much is contract W81K0023P0032 worth?
The government has obligated $817,019 on W81K0023P0032. Its current value, with exercised options, is $1,121,114. Its potential value, with all options, is $1,247,820.
Which agency awarded contract W81K0023P0032?
Medical Command (Department of the Army) awarded W81K0023P0032, with funding from Defense Health Agency (Department of Defense).
Was contract W81K0023P0032 competed?
The extent of competition for W81K0023P0032 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award